How much does gemtuzumab ozogamicin cost (current list price)?
Prices for gemtuzumab ozogamicin vary by country, payer type (hospital/insurer vs. retail), dose size, and product packaging. The provided information does not include any specific pricing or reimbursement data, so an exact current price can’t be stated here.
What determines the final price a hospital or patient pays?
Even when a “list price” exists, the amount paid can differ because of:
- The dose per treatment course (weight-based or protocol-based dosing affects total drug cost).
- Contracted discounts and rebates between manufacturers and payers.
- Insurance coverage rules (in the US, for example, oncology drugs are commonly paid through specific reimbursement channels rather than a “retail shelf price”).
- Supply and procurement arrangements for hospital pharmacies.
Is there a cheaper alternative or competing product?
If your goal is “lowest acquisition cost,” the price you pay may depend more on negotiated procurement and therapeutic alternatives than on the branded drug’s headline price. To compare options, you’d typically look at:
- Other therapies for the same indication.
- Biosimilar/alternate formulations only if available for the drug class (not just for the same drug name).
Can I find reliable pricing quickly in my country?
If you tell me the country (and whether you want “list price,” “insurance copay,” or “hospital acquisition cost”), I can point you to the most relevant way to look it up.
Reply with:
1) Country (e.g., US, UK, Canada, EU country)
2) Do you want list price, reimbursement rate, or patient out-of-pocket?